Related Experiment Video
Updated: Jan 23, 2026
10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
15.2K
Gastrointestinal Polyposis in Pediatric Patients
Suzanne P MacFarland1, Kristin Zelley1, Bryson W Katona2
1Division of Oncology, Department of Pediatrics.
Journal of Pediatric Gastroenterology and Nutrition
|June 19, 2019
Summary
Childhood gastrointestinal polyps, though rare, signal potential cancer risk and require genetic testing. This review guides pediatricians in managing these growths and family health risks.
Area of Science:
- Gastroenterology
- Pediatric Oncology
- Genetics
Background:
- Gastrointestinal polyps are mucosal growths with malignant potential.
- While uncommon in children, they can indicate hereditary cancer syndromes.
- Early detection and management are crucial for pediatric patients and their families.
Purpose of the Study:
- To review common and uncommon pediatric gastrointestinal polyposis syndromes.
- To outline clinical presentation, management, and surveillance strategies.
- To highlight malignancy risks and genetic implications in individuals under 21.
Main Methods:
- Literature review of pediatric gastrointestinal polyposis syndromes.
- Analysis of clinical presentation, management protocols, and surveillance guidelines.
- Evaluation of associated cancer risks and genetic testing recommendations.
Main Results:
- Pediatric polyposis syndromes necessitate specialized management due to potential for malignancy.
- Genetic testing is vital for identifying hereditary risk in affected children and families.
- Comprehensive surveillance protocols are essential for long-term patient outcomes.
Conclusions:
- A structured approach is needed for diagnosing and managing pediatric gastrointestinal polyps.
- Understanding genetic predispositions is key to family-wide risk assessment and prevention.
- This review provides a framework for gastroenterologists to manage pediatric polyposis effectively.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
271
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
199
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
260
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
01:26Anatomy of the Gastrointestinal System
2.7K
The human digestive system is an intricate and essential network for nutrient absorption and waste elimination. It encompasses the gastrointestinal (GI) tract and several accessory organs.
Here's a detailed walkthrough of this complex system:
Here's a detailed walkthrough of this complex system:
2.7K
01:20Histology of the Gastrointestinal (GI) Tract
3.3K
The GI tract, from beginning to end, is made up of four continuous tissue layers that adjust their structure according to their specific roles. These layers, from innermost to outermost, are known as the mucosa, submucosa, muscularis, and serosa, which are continuous with the mesentery.
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...
3.3K